Lawrence J. Coppey

3.9k total citations
60 papers, 2.8k citations indexed

About

Lawrence J. Coppey is a scholar working on Physiology, Surgery and Cellular and Molecular Neuroscience. According to data from OpenAlex, Lawrence J. Coppey has authored 60 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Physiology, 18 papers in Surgery and 12 papers in Cellular and Molecular Neuroscience. Recurrent topics in Lawrence J. Coppey's work include Pain Mechanisms and Treatments (16 papers), Biochemical effects in animals (16 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (13 papers). Lawrence J. Coppey is often cited by papers focused on Pain Mechanisms and Treatments (16 papers), Biochemical effects in animals (16 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (13 papers). Lawrence J. Coppey collaborates with scholars based in United States, Australia and Poland. Lawrence J. Coppey's co-authors include Mark A. Yorek, Eric P. Davidson, Donald D. Lund, Jill S. Gellett, Joyce A. Dunlap, Christine L. Oltman, Amey Holmes, Alexander Obrosov, Randy H. Kardon and Hanna Shevalye and has published in prestigious journals such as Diabetes, Journal of Neurophysiology and Scientific Reports.

In The Last Decade

Lawrence J. Coppey

60 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lawrence J. Coppey United States	31	1.5k	512	498	335	322	60	2.8k
Eric P. Davidson United States	30	1.4k 0.9×	520 1.0×	436 0.9×	337 1.0×	332 1.0×	63	2.5k
Martin J. Stevens United Kingdom	28	1.3k 0.9×	409 0.8×	406 0.8×	212 0.6×	278 0.9×	33	2.5k
Oliviero Danni Italy	34	1.8k 1.2×	820 1.6×	1.5k 3.0×	423 1.3×	256 0.8×	62	4.3k
Viktor R. Drel United States	27	1.2k 0.8×	416 0.8×	543 1.1×	271 0.8×	155 0.5×	50	2.5k
Kim K. Nickander United States	19	948 0.6×	230 0.4×	293 0.6×	212 0.6×	171 0.5×	27	1.9k
Ki Whan Hong South Korea	36	885 0.6×	252 0.5×	1.3k 2.6×	364 1.1×	424 1.3×	109	3.6k
Sookja Kim Chung Hong Kong	30	651 0.4×	358 0.7×	1.3k 2.6×	253 0.8×	209 0.6×	75	3.2k
S. A. Lattimer United States	29	2.0k 1.4×	771 1.5×	855 1.7×	522 1.6×	506 1.6×	39	3.9k
Ana I. Duarte Portugal	31	1.1k 0.7×	519 1.0×	1.2k 2.5×	567 1.7×	276 0.9×	59	3.0k
Hsinlin T. Cheng United States	20	1.2k 0.8×	464 0.9×	451 0.9×	351 1.0×	188 0.6×	38	2.4k

Countries citing papers authored by Lawrence J. Coppey

Since Specialization

Citations

This map shows the geographic impact of Lawrence J. Coppey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence J. Coppey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence J. Coppey more than expected).

Fields of papers citing papers by Lawrence J. Coppey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence J. Coppey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence J. Coppey. The network helps show where Lawrence J. Coppey may publish in the future.

Co-authorship network of co-authors of Lawrence J. Coppey

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence J. Coppey. A scholar is included among the top collaborators of Lawrence J. Coppey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence J. Coppey. Lawrence J. Coppey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Coppey, Lawrence J., et al.. (2020). <p>Progressive Loss of Corneal Nerve Fibers and Sensitivity in Rats Modeling Obesity and Type 2 Diabetes Is Reversible with Omega-3 Fatty Acid Intervention: Supporting Cornea Analyses as a Marker for Peripheral Neuropathy and Treatment</p>. Diabetes Metabolic Syndrome and Obesity. Volume 13. 1367–1384. 22 indexed citations

Davidson, Eric P., Lawrence J. Coppey, Hanna Shevalye, et al.. (2017). Impaired Corneal Sensation and Nerve Loss in a Type 2 Rat Model of Chronic Diabetes Is Reversible With Combination Therapy of Menhaden Oil, α-Lipoic Acid, and Enalapril. Cornea. 36(6). 725–731. 26 indexed citations

Obrosov, Alexander, Lawrence J. Coppey, Hanna Shevalye, & Mark A. Yorek. (2017). Effect of Fish oil Vs. Resolvin D1, E1, Methyl Esters of Resolvins D1 or D2 on Diabetic Peripheral Neuropathy. Journal of Neurology & Neurophysiology. 8(6). 17 indexed citations

Yorek, Matthew S., Matthew S. Yorek, Eric P. Davidson, et al.. (2016). Corneal Sensitivity to Hyperosmolar Eye Drops: A Novel Behavioral Assay to Assess Diabetic Peripheral Neuropathy. Investigative Ophthalmology & Visual Science. 57(6). 2412–2412. 14 indexed citations

Yorek, Matthew S., Matthew S. Yorek, Lawrence J. Coppey, et al.. (2016). Effect of Treatment with Salsalate, Menhaden Oil, Combination of Salsalate and Menhaden Oil, or Resolvin D1 of C57Bl/6J Type 1 Diabetic Mouse on Neuropathic Endpoints. Journal of Nutrition and Metabolism. 2016. 1–11. 20 indexed citations

Yorek, Matthew S., Matthew S. Yorek, Alexander Obrosov, et al.. (2016). Early vs. late intervention of high fat/low dose streptozotocin treated C57Bl/6J mice with enalapril, α-lipoic acid, menhaden oil or their combination: Effect on diabetic neuropathy related endpoints. Neuropharmacology. 116. 122–131. 23 indexed citations

Davidson, Eric P., Amey Holmes, Lawrence J. Coppey, & Mark A. Yorek. (2015). Effect of combination therapy consisting of enalapril, α-lipoic acid, and menhaden oil on diabetic neuropathy in a high fat/low dose streptozotocin treated rat. European Journal of Pharmacology. 765. 258–267. 29 indexed citations

Davidson, Eric P., Lawrence J. Coppey, Amey Holmes, & Mark A. Yorek. (2011). Effect of inhibition of angiotensin converting enzyme and/or neutral endopeptidase on vascular and neural complications in high fat fed/low dose streptozotocin-diabetic rats. European Journal of Pharmacology. 677(1-3). 180–187. 43 indexed citations

Davidson, Eric P., Lawrence J. Coppey, Amey Holmes, Brian L. Dake, & Mark A. Yorek. (2011). Effect of treatment of high fat fed/low dose streptozotocin-diabetic rats with Ilepatril on vascular and neural complications. European Journal of Pharmacology. 668(3). 497–506. 53 indexed citations

10.

Coppey, Lawrence J., Eric P. Davidson, Bao Lu, Craig Gérard, & Mark A. Yorek. (2010). Vasopeptidase inhibitor ilepatril (AVE7688) prevents obesity- and diabetes-induced neuropathy in C57Bl/6J mice. Neuropharmacology. 60(2-3). 259–266. 22 indexed citations

11.

Davidson, Eric P., Lawrence J. Coppey, Brian L. Dake, & Mark A. Yorek. (2010). Effect of Treatment of Sprague Dawley Rats with AVE7688, Enalapril, or Candoxatril on Diet-Induced Obesity. Journal of Obesity. 2011. 1–9. 30 indexed citations

12.

Davidson, Eric P., Lawrence J. Coppey, Nigel A. Calcutt, Christine L. Oltman, & Mark A. Yorek. (2010). Diet‐induced obesity in Sprague–Dawley rats causes microvascular and neural dysfunction. Diabetes/Metabolism Research and Reviews. 26(4). 306–318. 74 indexed citations

13.

Oltman, Christine L., et al.. (2010). Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic rats. European Journal of Pharmacology. 650(2-3). 556–562. 23 indexed citations

14.

Oltman, Christine L., et al.. (2007). Treatment of cardiovascular dysfunction associated with the metabolic syndrome and type 2 diabetes. Vascular Pharmacology. 48(1). 47–53. 20 indexed citations

15.

Oltman, Christine L., et al.. (2007). Vascular and neural dysfunction in Zucker diabetic fatty rats: a difficult condition to reverse. Diabetes Obesity and Metabolism. 10(1). 64–74. 54 indexed citations

16.

Davidson, Eric P., Lawrence J. Coppey, & Mark A. Yorek. (2005). Activity and expression of the vanilloid receptor 1 (TRPV1) is altered by long‐term diabetes in epineurial arterioles of the rat sciatic nerve. Diabetes/Metabolism Research and Reviews. 22(3). 211–219. 16 indexed citations

17.

Oltman, Christine L., Lawrence J. Coppey, Jill S. Gellett, et al.. (2005). Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats. American Journal of Physiology-Endocrinology and Metabolism. 289(1). E113–E122. 108 indexed citations

18.

Coppey, Lawrence J., Jill S. Gellett, Eric P. Davidson, Joyce A. Dunlap, & Mark A. Yorek. (2002). Changes in endoneurial blood flow, motor nerve conduction velocity and vascular relaxation of epineurial arterioles of the sciatic nerve in ZDF‐obese diabetic rats. Diabetes/Metabolism Research and Reviews. 18(1). 49–56. 55 indexed citations

19.

Coppey, Lawrence J., Jill S. Gellett, Eric P. Davidson, Joyce A. Dunlap, & Mark A. Yorek. (2001). Effect of Treating Streptozotocin‐Induced Diabetic Rats With Sorbinil, Myo‐Inositol or Aminoguanidine on Endoneurial Blood Flow, Motor Nerve Conduction Velocity and Vascular Function of Epineurial Arterioles of the Sciatic Nerve. Journal of Diabetes Research. 3(1). 21–36. 67 indexed citations

20.

Li, Wei-Gen, Lawrence J. Coppey, Robert M. Weiss, & Helgi Oskarsson. (2001). Antioxidant Therapy Attenuates JNK Activation and Apoptosis in the Remote Noninfarcted Myocardium after Large Myocardial Infarction. Biochemical and Biophysical Research Communications. 280(1). 353–357. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact